Medications for Graft-versus-host disease

Other names: GVHD

Graft-versus-host disease (GVHD) is a complication that can occur after a bone marrow transplant in which the newly transplanted material attacks the transplant recipient's body.

Drugs used to treat Graft-versus-host disease

Name Drug Class Updated
Ruxolitinib (systemic) (monograph) Drugs 14-Aug-2023
Ruxolitinib Multikinase inhibitors 14-Aug-2023
Belumosudil Selective immunosuppressants 13-Aug-2023
Tacrolimus (oral and injection) Calcineurin inhibitors 12-Aug-2023
Tacrolimus (systemic) (monograph) Drugs 12-Aug-2023
Rezurock Selective immunosuppressants 14-Jul-2023
Jakafi Multikinase inhibitors 10-Jul-2023
Imbruvica BTK inhibitors 10-Jul-2023
Ibrutinib BTK inhibitors 10-Jul-2023
Share this Article
Latest News
Related Drugs